Trademark: 76239484
Status Date
Friday, June 23, 2023
Registration Number
2660572
Registration Date
Tuesday, December 10, 2002
Filing Date
Thursday, April 12, 2001
Published for Opposition
Tuesday, September 25, 2001
Cancellation Date
Friday, June 23, 2023
5 pharmaceutical compound for use in the treatment and/or prevention of inflammation in genetic, cardiovascular, pulmonary, oncologic, and rheumatoid diseases and complications of surgical or interventional procedures
Jun 23, 2023
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Dec 10, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Feb 27, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 27, 2018
Teas Change Of Owner Address Received
Mar 7, 2012
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Mar 7, 2012
Registered And Renewed (First Renewal - 10 Yrs)
Mar 7, 2012
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Mar 5, 2012
Teas Section 8 & 9 Received
Oct 23, 2011
Teas Change Of Correspondence Received
Sep 6, 2008
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Aug 6, 2008
Assigned To Paralegal
Aug 4, 2008
Teas Section 8 & 15 Received
Apr 1, 2008
Case File In Ticrs
Dec 10, 2002
Registered-Principal Register
Sep 30, 2002
Allowed Principal Register - Sou Accepted
Sep 12, 2002
Assigned To Examiner
Sep 10, 2002
Statement Of Use Processing Complete
Aug 7, 2002
Sou Extension 2 Filed
Aug 7, 2002
Use Amendment Filed
Aug 8, 2002
Paper Received
May 20, 2002
Sou Extension 1 Granted
May 7, 2002
Sou Extension 1 Filed
May 7, 2002
Paper Received
Dec 18, 2001
Noa Mailed - Sou Required From Applicant
Sep 25, 2001
Published For Opposition
Sep 5, 2001
Notice Of Publication
Aug 7, 2001
Approved For Pub - Principal Register
Jul 23, 2001
Assigned To Examiner
Jul 20, 2001
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
